Trial Profile
A study comparing patients undergoing recanalization for chronic total occlusions (CTO)with either Orsiro Sirolimus-eluting stent (O-SES) or Zotarolimus-eluting stent (ZES)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Zotarolimus
- Indications Coronary artery disease
- Focus Therapeutic Use
- 27 Feb 2016 New trial record